Yes, although I don't know the size of the 'new' indication's market, not going for screening is a huge comedown commercially. I will keep them on my watch list to see the data and will make a decision after that.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.